Healthcare Investments By China Likely To Increase

BMI View: China's soft power in the African healthcare sector will become increasingly commercialised as its investment in the continent continues to promote sustainability over aid dependence. However, in Tanzania, 'brand China' has been significantly damaged by poor business practices. Although relations between the countries look strong in most other areas, BMI does not expect China to outperform in the pharmaceuticals sector; instead it will be Indian and European companies that will continue to dominate the pharmaceutical import market.

To read the full article, please choose one of the following options: